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Abstract-A1 adenosine receptors in coated vesicles have been characterized by radioligand binding and 
photoaflinity labelling. Saturation experiments with the antagonist 8-cyclopentyl-1 ,3-[3H]dipropyl-xanthine 
([3H]DPCPX) gave a Kdvalue of0.7 nM and a Bmax value of82± 13 fmol/mg protein. For the highly A1-selective 
agonist 2-chloro-~-[lH]cyclopentyladenosine ([3H]CCPA) a Kd value of 1.7 nM and a Bmax value of 
72 ± 29 fmol/mg protein was estimated. Competition of agonists for (3H]DPCPX binding gave a pharmacolo-
gical profile with R-JV6-phenylisopropyladenosine (R-PIA) > CCPA > S-PIA > 5'-N-ethylcarboxamido-
adenosine (NECA), which is identical to brain membranes. The competition curves were best fitted according 
to a two-site model, suggesting the existence of two affinity states. GTP shifted the competition curve for 
CCP A to the right and only one affinity state similar to the low affinity state in the absence of GTP was 
detected. The photoreactive agonist 2-azido-~-1251-p-hydroxyphenylisopropyladenosine ([125I]AHPIA) specifi-
cally Iabelied a single protein with an apparent molecular weight of 35,000 in coated vesicles, which is identical 
to A1 receptors Iabelied in brain membranes. Therefore, coated vesicles contain A1 adenosine receptors with 
similar binding characteristics as membrane-bound receptors, including GTP-sensitive high-affinity agonist 
binding. Photoaffinity labelling data suggest that A1 receptors in these vesicles are not a processed receptor 
fonn. These results confirm that A1 receptors in coated vesicles are coupled to a G-protein, and it appears that 
the A1 receptor systems in coated vesicles andin plasma membranes are identical. 
Key words: Adenosine receptors, coated vesicles, G-protein, radioligand, photoaffinity labelling, brain 
membranes. 
INTRODUCTION 
CoA TED vesicles are organelles which serve as 
vehicles for selective transport of macro-
molecules between different cell compartments 
[I, 2]. They have been shown to play a role in 
the regulation of the function of a variety "f 
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receptors, e.g. for growth factors, hormones 
and cell nutrients. Ligands for these receptors 
are internalized along with their receptors in a 
process called receptor-mediated endocytosis 
(for review see [3-S]). Some reports have also 
shown the presence in coated vesicles of recep-
tors that are coupled to guanyl nucleotide-
binding proteins (G-proteins), like opioid recep-
tors [6], ß-adrenergic receptors [7], musearlnie 
cholinergic receptors [8] and A 1 adenosine 
receptors [9], indicating that these receptors 
might be internalized via a similar mechanism. 
Receptor sequestration and down-regulation 
are regulatory processes which have been exten-
sively investigated for ß-adrenergic receptors 
[10, II]. The exact mechanism of receptor 
sequestration or internalization is unclear so 
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far, but the presence of ß-adrenergic receptors 
and other members of the family of 
G-protein.-coupled receptors suggests that 
coated vesicles may be involved in their trans-
location and redistribution. Furthermore, it has 
recently been shown that tyrosine residues 
located in the cytoplasmic tail of ß2-adrenergic 
receptors are involved in agonist-induced 
down-regulation of the receptor [12]. The direct 
implication of a cytoplasmic tyrosine for endo-
cytosis via coated vesicles which has been 
suggested for a number of receptors [2, 13] also 
points to a potential role of coated vesicles in 
the regulation of 0-protein-coupled receptors. 
In addition to the Iack of clear-cut evidence 
for a direct participation of coated vesicles in 
the regulation of G-protein-coupled receptors, 
differences have appeared between the 
G-protein-coupled receptor systems character-
ized in coated vesicles. A1 adenosine receptors 
have been shown tobe still functionally coupled 
to adenylate cyclase [9], while ß-adrenergic 
receptors seem to be, uncoupled from adenylate 
cyclase [7]. Opioid receptors in coated vesicles 
exhibited GTP-sensitive agonist binding [6]. 
Agonist binding to musearlnie acetylocholine 
receptors, however, has been demonstrated to 
be insensitive to OTP [8], indicating that these 
receptors are uncoupled from a G-protein. 
These reported differences between receptor 
systems in coated vesicles, which work 
according to similar principles in plasma 
membranes, led us to investigate high- and low-
affinity agonist binding, including regulation by 
GTP, to A1 adenosine receptors in coated 
vesicles in more detail; this enabled us to 
further establish 0-protein coupling of A1 
receptors in coated vesicles. F or this purpose, 
competition of agonists for the A1 selective 
antagonist radio Iigand 8-cyclopentyl-1 ,3-rH]-
dipropylxanthine ([3H]DPCPX) [14] was 
measured. In addition, saturation experiments 
with the new agonist 2-chloro-_Nf»-[3H]cyclo-
pentyladenosine ([3H]CCPA), which has been 
shown tobe suitable to detect A 1 receptors that 
are present only in low density [I 5], were per-
formed. Comparison with binding data from 
bovine brain membranes [16] and photoaffinity 
labelling data showed that A1 receptors in 
coated vesicles were similar to plasma 
membrane receptors and confirmed the pre-
sence of G-protein-coupled A1 receptors in 
coated vesicles. 
MATERIALSAND METHODS 
Materials 
[3H)CCPA was purchased from Du Pont-New 
England Nuclear (Dreieich, F. R.G.) and 
PHJDPCPX from ADlersharn Duchier 
(Braunschweig, F.R.G.). 2-Azido-~-p-hydroxy­
phenylisogropyladenosine. (AHPIA) was iodinated 
to give [I 5I]AHPIA with a specific radioactivity of 
about 74 TBqfmmol [17], CCPA was synthesized as 
previously described [ 18). All other chemieals were of 
the highest purity available. 
Preparation of membranes and coated vesic/es 
Membranes from rat brain were prepared as 
described earlier [19). Coated vesicles from bovine 
brain have been prepared as described recently [9]. 
The same procedure was used for the isolation of rat 
brain coated vesicles. Briefty, whole brains from 25-
30 rats ( ~ 35 g) were homogenized in isolation 
buffer [10 mM 2-(N-morpholino)ethanesulphonic 
acid (MES)fNaOH, IOOmM KCI, l mM EGTA, 
0.5mM MgC12, 0.1 mM DTI, 0.1 mM phenyl-
methylsulphonyl ftuoride, 0.02o/o NaN3, 7.,3 mU/ml 
bacitracin, pH 6.5) at a ratio of I :2 (w/v). After 
differential and density centrifugations the crude 
coated vesicles were loaded onto a Sephacryl S-1 000 
column ( 1.6 x 70 cm) equilibrated in isolation bufl'er. 
Coated vesicles were collected from peak II by centri-
fugation at I 00,000 g for 30 min. This preparation 
yielded 1-1.5 mg of coated vesicles. 
Radioligand binding 
Binding of [3H]DPCPX was performed according 
to Lohse et al. [14] and binding of [3H]CCPA was 
performed as described recently [15]. In competition 
experiments, I nM [3H]DPCPX with about 100 pg 
protein in a total volume of 250 111 was used. 
Nonspecific binding of [3H]DPCPX and f'H]CCPA 
was determined in the presence of 10 pM 
R-~·phenylisopropyladenosine (R-PIA) and l mM 
theopbylline, respectively. Adenosine deaminase was 
present in all binding assays at a concentration of 
0.2 Ujml. Each value was determined in duplicate. 
Data were analysed by nonlinear curve-fitting with 
the program SCTFIT as described [ 14]. 
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Fra. I. SOS-PAGE of coated vesicles purified on Sephacryl S-1000. Two-hundred micrograms of proteinwas 
loaded onto a 10°/o gel and the gel was stained with Coomassie Blue. Lane 1: rat brain membranes; lane 2: 
coated vesicles from rat brain; lane 3: coated vesicles from bovine brain. 
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FIG. 5. Photoaffinity Iabelling of A1 adenosine receptors in coated vesicles from bovine and rat brain. A 1 
receptors were photoaffinity Iabeiied as outlined in Materials and Methods. In coated vesicles from bovine 
(BCV) and rat brain (RCV) labelling of a band with a molecular weight of 35,000 is inhibited in the presence of 
I mM theophylline (THEO), indicating specific labelling. For comparison, labelling of rat brain membranes 
(RBM) is shown. 
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Photoaffinity labelfing 
Photoaffinity labelling of A1 receptors in brain 
membranes was performed with [125I]AHPIA at a 
concentration of about 200 pM as described [17, 20]. 
In brief, membranes (100 ll8 protein) or coated 
vesicles (200-400 llB protein) were incubated for 
2-3 h with [125I]AHPIA (500,000 c.p.m.) in a total 
volume of 7 50 ~tl in the dark in the presence and 
absence of 1 mM theophylline to define nonspecific 
labelling. Then membranes were UV -irradiated and 
prepared for SOs-PAGE on 1 Oo/o ge1s. The gels were 
stained with Coomassie Blue and then dried for 
autoradiography [17]. 
RESULTS 
Highly purified coated vesicles have been 
obtained by density gradient centrifugation and 
Sephacryl S-1 000 gel filtration from bovine and 
rat brain. Figure 1 shows the distinguished 
protein pattern of coated vesicles (lane 2) 
compared to the microsomal membrane frac-
tion (lane 1) from rat brain. It is also shown 
that the coated vesicle preparation from rat 
brain (lane 2) gave results comparable to the 
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TADLE I. SATURATION DATA FOR THE ANTAGONIST 
[3H]DPCPX AND THI! AGONIST (3H]CCPA 
Radioligand Kd value (nM) BJIJD value (fmol/mg) 
[3H]DPCPX 0.69 (0.34-1.41) 
[3H]CCPA 1.67 (0.72-3.85) 
82±13 
72±29 
Show!) are mean values from three experiments, K4 
values with 95o/o confidence Iimits and Bmu 
values ± S.E.M. 
well-established preparation of coated vesicles 
from bovine brain (lane 3; see also [9]). 
Coated vesicles from bovine brain 
membranes bound the A1 receptor-selective 
antagonist [3H]DPCPX with high affinity and in 
a saturable manner (Fig. 2). The saturation 
experiments gave a Kd value of 0.69 nM and a 
Bmu value of 82 fmolfmg protein (Table I). This 
affinity is similar to the Kd value of 0.22 nM 
deterrnined in bovine brain membranes [16). 
Competition of several agonists for [3H]DPCPX 
binding resulted in biphasic competition curves, 
if 0~.:=---~--------~--------------~~------~ 0.0 o.2 o. 4 o.a o.a 1.0 
CONCENTRATION OF I3HlOPCPX (nMl 
Fto. 2. Saturation of [3H]DPCPX binding to coated vesicles from bovine brain. Specific (e) and nonspecific 
binding ( 0) of the antagonist [3H]DPCPX are shown from a representative experiment. Nonlinear curve fitting 
gave a KrJ value of 0.4 nM and a Bavu. value of 59 fmolfmg protein. A Scatchard plot of the data is shown in the 
inset. 
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F1o. 3. Competition of CCPA for [sH]DPCPX binding to coated vesicles from bovine brain in the presenc::e or 
absence ofGTP. Shown is total binding of[3H]DPCPX in the absence (e) andin the presence of IOOpM GTP 
( 0) from a representative experiment. Nonlinear curve fitting of the control curve gave Kd values of 1.6 and 
53 nM for the high- and low-affinity states, respectively, with 55o/o ofthe receptors being in a high-aßinity state. 
A two-site fit was significantly better than a one-site fit (P < 0.005). In the presence of GTP only one affinity 
state was detected with a Kd value of 37 nM. 
indicating high- and low-affinity binding of the 
agonists (Table 2). About 50% of the receptors 
are in the high- and low-affinity states, respec-
tively. The rank order of potency for the 
agonists was R-PIA > CCPA > S-PIA > 
5' -N-ethylcarboxamidoadenosine (NECA), 
with a marked stereoselectivity for the PIA 
diastereomers, which is typical for an A1 adeno-
T ABLB 2. CoMPmTION OF AOONJST FOR. ('H)DPCPX 
BINDING TO A1 RECEPTORS IN COATED VBSJCLBS FROM 
BOVINE Blt.AIN MEMBRANPS 
K, (nM) 
Asonist High affinity 
R-PIA 0.04 (0.01-0.15) 
CCPA 1.1 (0.47-2.45) 
CCPA+GTP 
s-PIA 3.6 (0.6-20.9) 
NECA 77 (17-343) 
Low affinity 
8.8 (6.5-12.0) 
60 (32-116) 
38 (9-167) 
261 (66-1031) 
2733 (656-11,390) 
Data are means from three to six separate experi-
ments, X1 values are given with 95% confidence Iimits 
in parentheses. 
sine receptor. In cantrast to the classical phar-
macological profile for the A 1 adenosine 
receptor in rat brain, R-PIA is more potent 
than CCPA and S-PIA is more potent than 
NECA. However, these results match the 
binding data for this receptor subtype in bovine 
brain membranes [16]. 
The presence of high- and low-affinity agonist 
binding suggests tha t the receptors are 
G-protein coupled. To substantiate further this 
result, agonist competition for (3H]DPCPX 
binding was done in the presence and absence 
of GTP. Figure 3 shows competition curves for 
CCPA, with a biphasic curve in the absence of 
GTP. In the presence of GTP, the curve is 
shifted to the right and only one affinity state 
can be detected. The high- and low-affinity Kd 
values for CCPA in the absence of GTP are 1.1 
and 60 nM, respectively (Table 2). The single-
affinity state detected in the presence of GTP 
exhibits a Kd value of 38 nM (Table 2) and 
corresponds weil to the low-affinity state found 
in the absence of GTP. 
[3H]CCPA was also used to show agonist 
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F1o. 4. Saturation of (3H]CCP A binding to coated vesicles from bovine brain. The specific ( e) and nonspecific 
binding ( 0) of the agonist [3H]CCP A are shown from a represcntative experiment. A K~ value of 2 nM and a 
Bmu. value of 36 fmolfmg protein were calculated by nonlinear curve fitting. The inset shows the Scatchard plot 
of the data. 
radioligand binding to A1 receptors in coated 
vesicles. Figure 4 demonstrates that this new 
highly A1-selective agonist showed saturable 
binding. A Kd value of 1. 7 nM and a Brnu value 
of 72 fmolfmg protein was determined from 
saturation experiments (Table 1 ). 
To investigate possible structural differences 
_between the A1 adenosine receptor protein iden-
tified in coated vesicles compared to the plasma 
membrane receptor, the photoreactive adeno-
sine derivative [l251]AHPIA was used to Iabel 
covalently thc A1 receptors of bovine and rat 
brain coated vesicles. The autoradiogram of a 
SD8-PAGE shows specific labelling of a broad 
band with an apparent molecular weight of 
35,000 for both thc bovinc and rat coated 
vesicles (Fig. 5). The samc band has been 
Iabeiied in rat brain membranes (Fig. 5), andin 
bovinc brain membranes [16], suggesting that 
A1 receptors in membranes and coated vesicles 
are structurally identical. Tbc photoincorpo-
ration of the agonist [125I]AHPIA again indi-
cates the presence of high-affinity A1 receptors 
in a 0-protein-coupled state. 
DISCUSSION 
In the present study, the presence of A1 
adenosine receptors in coated vesicles in a 
0-protein-coupled state has been confirmed. 
Agonist competition for [3H]DPCPX gave 
biphasic curves with high- and low-affinity 
binding of a series of agonists. About 50o/o of 
the receptors were found in the high-affinity 
state in the absence of GTP, while GTP shifted 
virtually all receptors to the low-affinity state. 
The OTP regulation of agonist binding is 
indicative for interaction of A, receptors with a 
0-protein. The detection of high-affinity 
binding of the Ar·selective agonist [3H]CCPA 
corresponds with these findings. 
Opioid receptors in coated vesicles also cxhibit 
GTP-sensitive agonist binding (6]. High-affinity 
agonist binding has been demonstrated for 
musearlnie acetylcholine receptors in coated 
vesicles from bovine brain, although the signifi-
cance of tbis bigh-affinity state is unclcar. It 
seems to be unrelated to a 0-protein-coupled 
statc, because no GTP sensitivity of agonist 
744 G. GoNzALEZ-CALERO et al. 
binding has been found [8]. ß-Adrenergic recep-
tors in coated vesicles, on the other band, are 
uncoupled from adenylate cyclase and agonist 
binding is GTP insensitive [7], although G5 is 
present in coated vesicles [21 ]. These differences 
may be explained by the different G-proteins 
which couple these receptors to an effector 
system. There is evidence for tighter coupling of 
A1 receptors, and possibly other Gi-coupled 
receptors, to Gi compared to interaction of 
G5-coupled receptors with G5• The GTP regula-
tion of agonist binding to A1 adenosine recep-
tors is preserved during solubilization [22, 23], 
and A1 receptors co-purify with G-proteins [24], 
suggesting tight receptor-G-protein associa-
tion. Solubilization of G5-coupled ß-adrenergic 
receptors in the absence of an agonist, on the 
other band, induces loss of high-affinity agonist 
binding [25]. It is also conceivable that the 
microenvironment of receptors and G-proteins · 
plays a role in their coupling and, thus, 
receptor-G-protein coupling for different recep-
tors might be differently affected upon their 
translocation from plasma membranes into 
coated vesicles. 
Although the pharmacological profile for A1 
receptors in coated vesicles determined in this 
study matches the profile found in bovine brain 
membranes [16], some differences were 
observed for the Ki values for CCPA and 
NECA. These agonists exhibited six- to seven-
fold higher Kd values in coated vesicles 
compared to membranes. The same difference 
was observed for the Ka values for [3H]CCPA. 
These differences may be explained by different 
microenvironments of the receptor proteins in 
coated vesicles vs membranes [26]. lt is also not 
clear whether the G-protein composition in the 
coated vesicles is the same as in plasma 
membranes. lt has been shown that A, adeno-
sine receptors can interact with more than one 
G-protein [24]. Coupling of the receptor to 
different G-proteins could, therefore, also play 
a role in determining slightly different affinities 
for some agonists in coated vesicles vs 
membranes. 
The density of receptors found in coated 
vesicles is only about 1 0°/o of the density found 
in brain membranes (Table 1; [16]). It is, 
however, unlikely that the receptors found in 
coated vesicles represent a contamination of 
coated vesicles with plasma membranes. All 
major protein bands present in plasma 
membranes are virtually absent in the coated 
vesicle preparation (Fig. I). Even if we assume 
a I 0/o contamination with plasma membranes 
this could only account for 10°/o of the A1 
receptors detected in coated vesicles. The func-
tional significance of the receptors in coated 
vesicles could be based on a high turnover rate 
of the receptors at a low steady state 
concentration. 
G-protein coupling of A1 receptors in coated 
vesicles and, hence, high-affinity binding of 
agonists enabled us to characterize these recep-
tors by photoaffinity labelling with the agonist 
[1 2si]AHPIA [ 17]. Comparison of receptors 
Iabeiied in bovine brain coated vesicles, rat 
brain coated vesicles and rat brain membranes, 
revealed that they all have an apparent 
molecular weight of 35,000. This suggests that 
the receptors in coated vesicles are not a 
processed form. Successful agonist photoaffi-
nity labeHing in both rat and bovine brain 
coated vesicles supports that A1 receptors are 
G-protein-coupled in both species. 
The data in this paper show that the A, 
receptor protein in coated vesicles of bovine 
and rat brain is virtually indistinguishable from 
receptors in the plasma membrane and thus 
structurally intact. High- and low-affinity 
agonist binding have been demonstrated and, in 
addition, agonist binding is GTP regulated. 
Taken together with the previous finding of A1 
receptor-mediated inhibition of adenylate 
cyclase in coated vesicles [9], our present results 
confirm that the entire A1 receptor-effector 
system is present in these organelles. This may 
suggest that coated vesicles do indeed play a 
role in translocation and regulation of 
G-protein-coupled receptors. 
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